Company Overview of Pacific Equity Partners
Pacific Equity Partners is a private equity and venture capital firm specializing in buyouts, late venture, and late stage expansion capital. The firm does not invest in startups and unprofitable businesses. It also does not invest in companies with gambling and tobacco related businesses. The firm invests in all industries with a focus on industrial services, energy, consumer products, entertainment, big data, and financial services. It prefers to invest in companies based in Australia and New Zealand and exposure to other markets does not preclude an investment by the firm. It seeks to invest at least $100 million unless it is an add-on acquisition to an existing portfolio company, in comp...
126 Phillip Street
Sydney, NSW 2000
Founded in 1998
Key Executives for Pacific Equity Partners
Co-Founder and Managing Director
Compensation as of Fiscal Year 2014.
Pacific Equity Partners Key Developments
Orica Reportedly In Talks With Private Equity Firms For Sale Of Its Chemicals Division
Aug 6 14
Orica Limited (ASX:ORI) is understood to have engaged with Pacific Equity Partners, Kohlberg Kravis Roberts & Co. L.P. (NYSE:KKR), Archer Capital and The Carlyle Group LP (NasdaqGS:CG) about a potential sale of its $1 billion chemicals division, reported The Australian citing sources. Orica confirmed it would spin off its chemicals business either via a demerger or a sale. The sources said that private equity firms would be the likely contenders for the business should it opt for a sale rather than a spin off. Orica, through its advisors The Goldman Sachs Group, Inc. (NYSE:GS), Citibank, National Association and Lazard Ltd. (NYSE:LAZ), held talks with potential suitors several weeks ago about their interest. Pacific Equity Partners, KKR, Archer and Carlyle were among those engaged, but analysts said that Bain Capital, LLC would be a logical suitor, as would The Blackstone Group L.P. (NYSE:BX), TPG Capital, L.P. and CVC Group. Some market sources hosed down the likelihood of interest by Ashland Inc. (NYSE:ASH) or Brenntag AG (XTRA:BNR). Analysts value the chemicals business at $800 million-$1 billion. Other sources said a demerger of the Orica business rather than a trade sale was the more likely option, contrasting with the view of some analysts, Orica said it had received a number of unsolicited inquires from third parties expressing non-binding interest to acquire the operation. A demerger would create a separate listing for the chemicals business.
Pacific Equity Partners Presents at AVCJ Private Equity and Venture Forum Singapore 2014, Jul-17-2014 09:30 AM
Jul 14 14
Pacific Equity Partners Presents at AVCJ Private Equity and Venture Forum Singapore 2014, Jul-17-2014 09:30 AM. Venue: Four Seasons Hotel, 190 Orchard Boulevard, Singapore 248646, Singapore. Speakers: Timothy J. Sims, Co-Founder and Managing Director.
Elders Confirms Interest From Several Companies
Jul 9 14
Mark Allison, Chief Executive Officer of Elders Limited (ASX:ELD), has confirmed several parties have been looking at the company but no formal offer had been put to the board. Fairfax Media Limited (ASX:FXJ) has reported that Pacific Equity Partners, Wellard Pty. Ltd. and Asian investors have been "kicking the tyres" on the company. He said that he was aware private equity and other parties had been running the ruler over the company. "Private equity [groups] are looking at us, given we are getting to the point of a turnaround," he said. "There is no formal discussion. We are just running the business as per our operational priorities, being methodical and getting the debt down to an acceptable level."
Similar Private Companies By Industry
Recent Private Companies Transactions